<?xml version="1.0"?>

<!DOCTYPE owl [
	<!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#">
	<!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#">
	<!ENTITY xsd "http://www.w3.org/2001/XMLSchema#">
	<!ENTITY owl "http://www.w3.org/2002/07/owl#">
	<!ENTITY cc "http://web.resource.org/cc/#">
	<!ENTITY project "http://ebiquity.umbc.edu/ontology/project.owl#">
	<!ENTITY person "http://ebiquity.umbc.edu/ontology/person.owl#">
	<!ENTITY pub "http://ebiquity.umbc.edu/ontology/publication.owl#">
	<!ENTITY assert "http://ebiquity.umbc.edu/ontology/assertion.owl#">
]>

<!--

This ontology document is licensed under the Creative Commons
Attribution License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/2.0/ or send a letter to
Creative Commons, 559 Nathan Abbott Way, Stanford, California
94305, USA.

-->

<rdf:RDF 
		xmlns:rdf = "&rdf;"
		xmlns:rdfs = "&rdfs;"
		xmlns:xsd = "&xsd;"
		xmlns:owl = "&owl;"
		xmlns:cc = "&cc;"
		xmlns:project = "&project;"
		xmlns:person = "&person;"
		xmlns:pub = "&pub;"
		xmlns:assert = "&assert;">
	<pub:InProceedings rdf:about="http://ebiquity.umbc.edu/paper/html/id/417/A-hybrid-intelligent-system-for-formulation-of-BCS-Class-II-drugs-in-hard-gelatin-capsules">
		<rdfs:label><![CDATA[A hybrid intelligent system for formulation of BCS Class II drugs in hard gelatin capsules]]></rdfs:label>
		<pub:title><![CDATA[A hybrid intelligent system for formulation of BCS Class II drugs in hard gelatin capsules]]></pub:title>
		<pub:publishedOn rdf:datatype="&xsd;dateTime">2002-11-18T00:00:00-05:00</pub:publishedOn>
		<pub:abstract><![CDATA[In this paper, we describe a hybrid intelligent system for formulation of BCS Class II drugs in hard gelatin capsules. Several significant challenges are involved in drug-formulation: the active ingredients and the fillers in the capsule must be chemically compatible according to bio-pharmaceutical principles; the formulation must be manufacturable; and it must meet the prescribed drug release requirement. Traditional trial and error approach to drug-formulation design is too costly and time consuming to meet the increasing demand for new drugs. To answer these challenges, we have developed a prototype hybrid intelligent system for automatic drug formulation. This system consists of a rule-based Expert System (ES) that conducts formulation design according to Biopharmaceutical Classification of drugs and a neural network (NN) that predicts the quality of the formulation recommended by ES. Through interaction between the two modules, the hybrid system forms a (re) formulation-prediction cycle, and the quality of the formulation is improved with each iteration. The hybrid system is tested with sample drugs and is shown to be able to produce formulations with desirable performance measures.]]></pub:abstract>
		<pub:pages><![CDATA[1987- 1991]]></pub:pages>
		<pub:volume><![CDATA[4]]></pub:volume>
		<pub:counter>4669</pub:counter>
		<pub:booktitle><![CDATA[Proceedings of the 9th International Conference on Neural Information Processing]]></pub:booktitle>
		<pub:author>
			<rdf:List>
				<rdf:first>
					<person:Person rdf:about="http://ebiquity.umbc.edu/person/html/Yun/Peng"><person:name><![CDATA[Yun Peng]]></person:name><rdfs:label><![CDATA[Yun Peng]]></rdfs:label></person:Person>
				</rdf:first>
				<rdf:rest>					<rdf:List>
						<rdf:first>
							<person:Person rdf:about="http://ebiquity.umbc.edu/person/html/Gunjan/Kalra"><person:name><![CDATA[Gunjan Kalra]]></person:name><rdfs:label><![CDATA[Gunjan Kalra]]></rdfs:label></person:Person>
						</rdf:first>
						<rdf:rest>							<rdf:List>
								<rdf:first>
									<person:Person rdf:about="http://ebiquity.umbc.edu/person/html/Mintong/Guo"><person:name><![CDATA[Mintong Guo]]></person:name><rdfs:label><![CDATA[Mintong Guo]]></rdfs:label></person:Person>
								</rdf:first>
								<rdf:rest>									<rdf:List>
										<rdf:first>
											<person:Person rdf:about="http://ebiquity.umbc.edu/person/html/Larry/Augsburger"><person:name><![CDATA[Larry L Augsburger]]></person:name><rdfs:label><![CDATA[Larry L Augsburger]]></rdfs:label></person:Person>
										</rdf:first>
										<rdf:rest rdf:resource="&rdf;nil" />
									</rdf:List>
								</rdf:rest>
							</rdf:List>
						</rdf:rest>
					</rdf:List>
				</rdf:rest>
			</rdf:List>
		</pub:author>
		<pub:firstAuthor>
<person:Person rdf:about="http://ebiquity.umbc.edu/person/html/Yun/Peng"><person:name><![CDATA[Yun Peng]]></person:name><rdfs:label><![CDATA[Yun Peng]]></rdfs:label></person:Person>
		</pub:firstAuthor>
		<pub:softCopy><pub:SoftCopy>
			<pub:softCopyFormat><![CDATA[PDF Document]]></pub:softCopyFormat>
			<pub:softCopyURI><![CDATA[http://ebiquity.umbc.edu/get/a/publication/421.pdf]]></pub:softCopyURI>
			<pub:softCopySize>304997</pub:softCopySize>
			</pub:SoftCopy>
			</pub:softCopy>
	</pub:InProceedings>

<rdf:Description rdf:about="">
	<cc:License rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
</rdf:Description>

</rdf:RDF>
